Muscle Pharm Corp (MSLP) 2.0500 $MSLP MusclePharm

New Post Public Reply Private Reply Replies (0) Message Board

Aug 18, 2016 at 7:14 AM

Muscle Pharm Corp (MSLP) 2.0500 $MSLP

MusclePharm Reports 2016 Second Quarter Financial Results
PR Newswire - Tue Aug 09, 3:42PM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition company, today announced financial results for the quarter ended June 30, 2016.

MusclePharm Corporation Announces More Than $45 Million in Future Commitments Trimmed To Date
PR Newswire - Thu May 26, 3:15PM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition company, announced a reduction of more than $45 million in future commitments to date as part the Company's ongoing restructuring program.

MusclePharm Reports 2016 First Quarter Financial Results
PR Newswire - Tue May 10, 4:00PM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition Company, today announced financial results for the first quarter ended March 31, 2016.

MusclePharm Enters into Agreement for the Sale of BioZone Laboratories
PR Newswire - Wed Apr 27, 8:49AM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance-lifestyle sports nutrition company, announced today that it has entered into a definitive agreement for the sale of its wholly-owned subsidiary, BioZone Laboratories, Inc. ("BioZone"

.

MusclePharm Reports 2015 Fourth-Quarter And Full-Year Financial Results
PR Newswire - Thu Mar 17, 6:00AM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition company, today announced financial results for the fourth quarter and full year ended December 31, 2015.

MusclePharm Focused on Expanding Market Share in Growing Protein Sector
PR Newswire - Tue Jan 19, 7:15AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition company, announced the planned introduction of two protein products: Combat 100% Whey(TM) and Combat Pro-Gel(TM).

MusclePharm Completes $10 Million Financing
WorldStockWire - Thu Jan 14, 10:30PM CST
MusclePharm Corporation (OTCQB: MSLP) a scientifically-driven, performance lifestyle sports nutrition company, today announced the completion of a financing agreement with Prestige Capital Corporation ("Prestige Capital"

in the initial amount of $10 million.

MusclePharm Executive Chairman Issues Letter to Shareholders
BusinessWire - Thu Dec 10, 7:00AM CST
MUSCLEPHARM CORPORATION (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, announced that it has released a letter from Executive Chairman Ryan Drexler to update shareholders on the current status of the Company.

MusclePharm to Explore Sale of Its BioZone Laboratories Nevada Subsidiary's Business
BusinessWire - Tue Nov 17, 7:00AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically driven, performance-lifestyle sports nutrition company, today announced that it has previously retained an investment banker to explore the sale of all or substantially all of the assets of its BioZone Laboratories Inc. subsidiary.

Hynes Keller & Hernandez, LLC Announces Investigations of AAC Holdings, Inc., Muscle Pharm Corp., and Hill International, Inc.
PR Newswire - Wed Sep 23, 6:35AM CDT
Hynes Keller & Hernandez, LLC is investigating potential claims against AAC Holdings, Inc., Hill International, Inc. and Muscle Pharm Corp. as detailed below.
HIL: 4.33 (-0.03), AAC: 18.00 (-0.28)

MusclePharm Corp. Statement on SEC Settlement
BusinessWire - Tue Sep 08, 1:29PM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, today announced approval of the final settlement with the United States Securities and Exchange Commission, as was announced by the SEC earlier today.

SEC Charges Sports Nutrition Company With Failing to Properly Disclose Perks for Executives
M2 - Tue Sep 08, 11:21AM CDT
The Securities and Exchange Commission today charged a sports supplements and nutrition company with committing a series of accounting and disclosure violations, including the failure to properly report perks provided to its executives as compensation.

MusclePharm to Position Company for Future Profitability
BusinessWire - Tue Aug 25, 3:45PM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, today announced plans to better focus and align the company's resources toward profitable growth. The company believes this initiative could yield cost savings in excess of $20 million on an annual basis going forward, and profitability in 2016 and beyond. MusclePharm will be working to increase operating profit margins to 10 percent and earnings before interest, taxes, depreciation and amortization (EBITDA) margins to 15 percent by 2020.

Glancy Prongay & Murray LLP is Investigating Muscle Pharm Corp. Board of Directors
BusinessWire - Tue Jul 21, 5:39PM CDT
Glancy Prongay & Murray LLP is investigating potential claims against the Board of Directors of Muscle Pharm Corp. ("Muscle Pharm" or the "Company"

(OTC:MSLP). This investigation concerns the Company's May 8, 2015 amendments to its By-laws and whether the Board of Directors of Muscle Pharm breached their fiduciary duties to stockholders by approving amendments which may place undue burden on stockholders' ability to nominate and elect competing directors to the incumbent slate.

MusclePharm Announce Signing UFC Fighters Robbie Lawler, Luke Rockhold and Paige VanZant
Marketwired - Wed Jul 08, 9:00AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company announced signing welterweight champion Robbie Lawler, number one middleweight contender Luke Rockhold, and rising star Paige VanZant in the strawweight division. Robbie Lawler will be featured in the co-main event at UFC 189 in Las Vegas this week to defend his welterweight title.

MusclePharm Announces Appointment of Experienced Nutrition and Fitness Executive and Investment Manager Ryan Drexler to Board of Directors
Marketwired - Thu Jun 25, 8:03AM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically driven, performance-lifestyle sports nutrition company, today announced Ryan Drexler as its new chairman. The announcement is a part of the Company's continued effort to institute best-in-class corporate governance practices and fulfills its commitment to separate the roles of CEO and Chairman. Mr. Drexler is an experienced investor and manages Consac, LLC, based in Beverly Hills, California. Consac, which invests in publicly traded and venture companies in the health and wellness space, has made significant investments in MusclePharm's stock in the public market and in private transactions.

Author of Body-for-LIFE and Former CEO/Owner of EAS Performance Nutrition Bill Phillips Joins MusclePharm
Marketwired - Tue Jun 16, 6:00AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company announces fitness and bodybuilding pioneer Bill Phillips joining MusclePharm as Strategic Advisor and Chief Editor of Content. Mr. Phillips is one of the most credible voices in the world on fitness and brings with him three decades of experience and knowledge in the nutritional and supplement field and a proven leader in science-based products. As a part of his scope, Mr. Phillips will also develop with MusclePharm a direct selling model aimed at the over 40 demographic -- a segment that the Company has not yet had a significant penetration in. This is expected to be launched by early 2016.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...